Alan Warrander
Plus aucun poste en cours
Historique de carrière de Alan Warrander
Anciens postes connus de Alan Warrander
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Incanthera Plc
 Incanthera Plc Pharmaceuticals: MajorHealth Technology Incanthera Plc operates as a holding company, which focuses on drug discovery and development of targeted medicines for the treatment of cancer. The firm products include Sol, EP0015, Equin & Duo-C. The company was founded on March 2, 2010 and is headquartered in Manchester, the United Kingdom. | Directeur/Membre du Conseil | 23/10/2017 | 28/02/2022 |
| Independent Dir/Board Member | 23/10/2017 | 28/02/2022 | |
Objective Capital Ltd.
 Objective Capital Ltd. Investment Banks/BrokersFinance Objective Capital Ltd. provides investment research. The company is based in London, UK. The British company was founded by Gabriel Didham. | Analyst-Equity | 21/10/2010 | - |
Incanthera Research & Development Ltd.
 Incanthera Research & Development Ltd. Medical DistributorsDistribution Services Incanthera Research & Development Ltd. develops drug delivery solutions for solid tumor chemotherapy. It offers cancer therapies, such as ICT01-2588, a vascular disrupting agent and drug delivery platform for lung and prostate cancer; and ICT03-Es5, a bioreductive anticancer agent for lung, liver, and breast cancer. The company was founded by Alan McGowan, Paul Loadman, Laurence Patterson, Andrew John Michael Duley, John Anthony Hadfield, Robert Falconer, and Jason Gill in 2010 and is headquartered in Manchester, the United Kingdom. | Directeur/Membre du Conseil | - | - |
| ONCOLYTICS BIOTECH INC. | Corporate Officer/Principal | 14/12/2009 | - |
Formation de Alan Warrander
| University of Birmingham | Doctorate Degree |
| University of St. Andrews | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 6 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ONCOLYTICS BIOTECH INC. | Health Technology |
 | Health Technology |
| Entreprise privées | 2 |
|---|---|
Objective Capital Ltd.
Objective Capital Ltd. Investment Banks/BrokersFinance Objective Capital Ltd. provides investment research. The company is based in London, UK. The British company was founded by Gabriel Didham. | Finance |
Incanthera Research & Development Ltd.
Incanthera Research & Development Ltd. Medical DistributorsDistribution Services Incanthera Research & Development Ltd. develops drug delivery solutions for solid tumor chemotherapy. It offers cancer therapies, such as ICT01-2588, a vascular disrupting agent and drug delivery platform for lung and prostate cancer; and ICT03-Es5, a bioreductive anticancer agent for lung, liver, and breast cancer. The company was founded by Alan McGowan, Paul Loadman, Laurence Patterson, Andrew John Michael Duley, John Anthony Hadfield, Robert Falconer, and Jason Gill in 2010 and is headquartered in Manchester, the United Kingdom. | Distribution Services |
- Bourse
- Insiders
- Alan Warrander
- Expérience
